Temporal changes in prevalence of antimicrobial resistance in 23 U.S. hospitals

Emerging Infectious Diseases

Volumn 8, Issue 7, 2002, Pages 697-701

  Fridkin, Scott K ^a,c   Hill, Holly A ^b   Volkova, Nataliya V ^b   Edwards, Jonathan R ^a   Lawton, Rachel M ^a   Gaynes, Robert P ^a   McGowan Jr , John E ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b EMORY UNIVERSITY   (United States)

^c NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFTAZIDIME; CIPROFLOXACIN; OFLOXACIN; OXACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CHI SQUARE TEST; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; ENTEROBACTER; ESCHERICHIA COLI; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; TIME; UNITED STATES;

EID: 0036310649     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0807.010427     Document Type: Article

References (26)

1. Control of antimicrobial resistance in the health care system
2. Preventing the emergence of antimicrobial resistance: A call for action by clinicians, public health officials, and patients
3. Survey of infections due to Staphylococcus species: Frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific Region for the SENTRY Antimicrobial Surveillance Program, 1997-1999
4. Characterization of Pseudomonas aeruginosa isolates: Occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the Global SENTRY Antimicrobial Surveillance Program, 1997-1999
5. Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: Results from the SENTRY Antimicrobial Surveillance Program, 1997-1999
6. Evidence of interhospital transmission of extended-spectrum β-lactam-resistant Klebsiella pneumoniae in the United States, 1986-1993
7. National nosocomial infections surveillance (NNIS): Description of surveillance methods
8. Surveillance of antimicrobial use and antimicrobial resistance in U.S. hospitals: Project ICARE Phase 2
9. Ability of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens: A survey of Project ICARE laboratories
10. National surveillance of nosocomial blood stream infection due to Candida albicans: Frequency of occurrence and antifungal susceptibility in the SCOPE Program
11. Magnitude and prevention of nosocomial infections in the intensive care unit
12. Antimicrobial resistance in intensive care units
13. Are the epidemiology and microbiology of methicillin-resistant Staphylococcus aureus changing?
14. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus-Minnesota and North Dakota, 1997-1999
15. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk
16. National Nosocomial Infections Surveillance (NNIS) report, data summary from January 1990-May 1999
17. Treatment failure due to extended spectrum β-lactamase
18. Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center
19. Trends in antimicrobial drug prescribing in office-based physicians in the United States
20. Characteristics of hospitals and infection control professionals participating in the National Nosocomial Infections Surveillance System 1999
21. Antimicrobial resistance prevalence rates in hospital antibiograms reflect prevalence rates in pathogens associated with hospital-acquired infections